SCHEMBL7319562

SCHEMBL7319562

O=[N+]([O-])c1ccc(NN=C(Cl)c2ccccn2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.55
MAPT P10636 12/20 0.48
KMT2A Q03164 10/20 0.48
ALDH1A1 P00352 9/20 0.48
GAA P10253 7/20 0.48
HTT P42858 6/20 0.48
MEN1 O00255 8/20 0.48
TDP1 Q9NUW8 3/20 0.48
MMP14 P50281 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
SNCA P37840 1/20 0.47
RAB9A P51151 8/20 0.47
NPC1 O15118 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
KLF5 Q13887 1/20 0.47
PKM P14618 1/20 0.47
ALOX12 P18054 2/20 0.47
GFER P55789 2/20 0.47
KDM4E B2RXH2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319559 1.00 KDR (0.55) KDRMAPTKMT2AALDH1A1GAA
SCHEMBL16592576 0.79 KDR (0.81) KDRMAPTKMT2AHTTMEN1
SCHEMBL14832051 0.77 L3MBTL1 (0.53) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL14832052 0.77 L3MBTL1 (0.53) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL7319072 0.76 ALDH1A1 (0.56) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL7319081 0.76 ALDH1A1 (0.56) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL11676120 0.76 MAPT (0.60) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL31483978 0.76 MAPT (0.60) MAPTKMT2AALDH1A1GAAHTT
SCHEMBL28871812 0.76 KDR (0.64) KDRMAPTKMT2AALDH1A1GAA
SCHEMBL7319047 0.75 MAPT (0.47) MAPTKMT2AALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 KDR 2396/4885MAPT 2674/4885KMT2A 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.